Conflicts of interest at the NIH - Resolving the problem

New England Journal of Medicine

Volumn 351, Issue 10, 2004, Pages 955-957

  Steinbrook, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CONFLICT; DRUG INDUSTRY; EMPLOYEE; ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE ORGANIZATION; PRIORITY JOURNAL; REVIEW; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CONFLICT OF INTEREST; CONSULTATION; ECONOMICS; FOOD AND DRUG ADMINISTRATION; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; PERSONNEL; POLICY; STANDARD; UNITED STATES; UNIVERSITY HOSPITAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ACADEMIC MEDICAL CENTERS; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; CONSULTANTS; DISCLOSURE; DRUG INDUSTRY; NATIONAL INSTITUTES OF HEALTH (U.S.); ORGANIZATIONAL POLICY; RESEARCH PERSONNEL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 4344594674     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp048235     Document Type: Review

References (5)

1. Willman D. Stealth merger: drug companies and government medical research. Los Angeles Times. December 7, 2003:A1.
2. Steinbrook R. Financial conflicts of interest and the NIH. N Engl J Med 2004;350:327-30.
3. Zerhouni EA. Testimony before the House Energy and Commerce Oversight Investigations Subcommittee, June 22, 2004. (Accessed August 13, 2004, at http://olpa.od.nih.gov/hearings/108/session2/testimonies/conflictc.asp.)
4. Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Policies: a working group of the Advisory Committee to the Director National Institutes of Health, June 22, 2004. (Accessed August 13, 2004, at http://www.nih.gov/about/ethics_COI_panelreport.pdf.)
5. Willman D. NIH is pressured to bar drug industry stipends. Los Angeles Times. August 6, 2004:A1.